These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11397923)

  • 1. Cancer research. Transatlantic war over BRCA1 patent.
    Balter M
    Science; 2001 Jun; 292(5523):1818. PubMed ID: 11397923
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory identification of hereditary risk of breast and ovarian cancer.
    Frank TS
    Curr Opin Biotechnol; 1999 Jun; 10(3):289-94. PubMed ID: 10361081
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW
    Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer genes--what are the real risks?
    Easton D
    Nat Genet; 1997 Jul; 16(3):210-1. PubMed ID: 9207777
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic testing for cancer: a complex decision.
    Harv Womens Health Watch; 2001 Feb; 8(6):2-4. PubMed ID: 11175466
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel germline in frame deletion (4128del3) of the BRCA2 gene detected in a breast/ovarian cancer family with fallopian tube and brain tumors identified in the north of France.
    Demange L; Noguchi T; Sauvan R; Moyal-Amsellem N; Birnbaum D; Eisinger F; Sobol H
    Hum Mutat; 2001 Feb; 17(2):155. PubMed ID: 11180606
    [No Abstract]   [Full Text] [Related]  

  • 8. BRCA: the breast, ovarian, and other cancer genes.
    Boyd J
    Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.
    Tercyak KP; Lerman C; Peshkin BN; Hughes C; Main D; Isaacs C; Schwartz MD
    Health Psychol; 2001 May; 20(3):217-22. PubMed ID: 11403219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of breast cancer: can we use today's information?
    Bell NN
    Manag Care Interface; 1998 May; 11(5):52-6. PubMed ID: 10181553
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychological impact of receiving a BRCA1/BRCA2 test result.
    Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
    Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three novel BRCA2 germline mutations (1864 delT, 6132 del4, 8208 del5) detected in breast cancer families identified in the south of France.
    Noguchi T; Sauvan R; Moyal-Amsellem N; Boubli L; Eisinger F; Birnbaum D; Sobol H
    Hum Mutat; 2001 Feb; 17(2):155. PubMed ID: 11180605
    [No Abstract]   [Full Text] [Related]  

  • 13. The battle over BRCA1 goes to court; BRCA2 may be next.
    Marshall E
    Science; 1997 Dec; 278(5345):1874. PubMed ID: 9417630
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. French researchers take a stand against cancer gene patent.
    Butler D; Goodman S
    Nature; 2001 Sep; 413(6852):95-6. PubMed ID: 11557932
    [No Abstract]   [Full Text] [Related]  

  • 16. The Oncormed approach to genetic testing.
    Carter CL; Scott JA; Glauber PM; Murphy PD
    Genet Test; 1997; 1(2):137-44. PubMed ID: 10464638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?
    Capalbo C; Buffone A; Vestri A; Ricevuto E; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
    J Clin Oncol; 2007 Jun; 25(18):2632-4; author reply 2634-5. PubMed ID: 17577048
    [No Abstract]   [Full Text] [Related]  

  • 19. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
    van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
    Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast cancer.
    Robson ME; Boyd J; Borgen PI; Cody HS
    Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.